Cue Health Stock Price To Sales
Cue Health fundamentals help investors to digest information that contributes to Cue Health's financial success or failures. It also enables traders to predict the movement of Cue Stock. The fundamental analysis module provides a way to measure Cue Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cue Health stock.
Cue |
Cue Health Company Price To Sales Analysis
Cue Health's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Cue Health Price To Sales | 0.36 X |
Most of Cue Health's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cue Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, Cue Health has a Price To Sales of 0.3634 times. This is 98.3% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The price to sales for all United States stocks is 96.82% higher than that of the company.
Cue Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cue Health's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cue Health could also be used in its relative valuation, which is a method of valuing Cue Health by comparing valuation metrics of similar companies.Cue Health is currently under evaluation in price to sales category among its peers.
Cue Fundamentals
| Return On Equity | -0.95 | |||
| Return On Asset | -0.31 | |||
| Operating Margin | (4.38) % | |||
| Current Valuation | 5.46 M | |||
| Shares Outstanding | 159.09 M | |||
| Shares Owned By Insiders | 11.56 % | |||
| Shares Owned By Institutions | 52.80 % | |||
| Number Of Shares Shorted | 776.46 K | |||
| Price To Earning | 16.86 X | |||
| Price To Book | 0.10 X | |||
| Price To Sales | 0.36 X | |||
| Revenue | 70.94 M | |||
| Gross Profit | (17.95 M) | |||
| EBITDA | (240.44 M) | |||
| Net Income | (373.46 M) | |||
| Cash And Equivalents | 363.12 M | |||
| Cash Per Share | 2.45 X | |||
| Total Debt | 47.94 M | |||
| Debt To Equity | 0.09 % | |||
| Current Ratio | 2.95 X | |||
| Book Value Per Share | 1.26 X | |||
| Cash Flow From Operations | (137.81 M) | |||
| Short Ratio | 1.60 X | |||
| Earnings Per Share | (2.13) X | |||
| Price To Earnings To Growth | 0.52 X | |||
| Target Price | 0.5 | |||
| Number Of Employees | 726 | |||
| Beta | 1.09 | |||
| Market Capitalization | 6.9 M | |||
| Total Asset | 339.79 M | |||
| Retained Earnings | (591.54 M) | |||
| Working Capital | 66.9 M | |||
| Current Asset | 115.52 M | |||
| Current Liabilities | 51.82 M | |||
| Net Asset | 339.79 M |
About Cue Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cue Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cue Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cue Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Cue Stock
If you are still planning to invest in Cue Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cue Health's history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |